Stay updated with breaking news from Bruce Cree. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new MRI imaging data from the Phase 3 clinical trial showing UPLIZNA reduced the formation of subclinical (asymptomatic) optic
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new MRI imaging data from the Phase 3 clinical trial showing UPLIZNA reduced the formation of subclinical (asymptomatic) optic nerve lesions in people with NMOSD. These findings are being presented during the 49th an...
-- Analyses suggest the B-cell-depleting mechanism of UPLIZNA did not interfere with important immune activity, including COVID-19 infection defenses and antibody levels from childhood vaccines -- Horizon
Autologous hematopoietic stem cell therapy does not outperform disease-modifying therapy in patients with multiple sclerosis, two new studies suggest.
New research goes "a step further" than previous studies by revealing a population of T cells in multiple sclerosis that may be responding directly to EBV during active viral disease, experts say.